NeoGenomics, Inc. Profile Avatar - Palmy Investing

NeoGenomics, Inc.

NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pat…
Medical - Diagnostics & Research
US, Fort Myers [HQ]
NEO/Financials
Wall Street · Earnings · Institutional Sentiment

Analysts

Earnings
Reported
Past Estimate Consensus
Future Estimate Consensus
EPS Revenue EBITDA EBIT SGA
FY EPS Revenue [mil.] Profit [mil.] EBITDA [mil.] EBIT [mil.] Expenses · SGA [mil.]
E E E E E E
All monetary values are presented in USD ($). E stands for Estimate.
2015 0.0200 -0.004 87 99 1 0.54 2 1 2 -10 35 51
2016 -0.0419 0.136 99 245 -2 -4 3 29 -5 4 45 105
2017 -0.0743 0.119 244 257 -5 -3 29 20 6 0.41 99 107
2018 -0.0108 0.181 258 271 0.85 1 24 21 3 6 113 79
2019 0.0288 0.277 276 406 2 6 31 31 10 10 114 147
2020 0.0797 0.072 408 443 8 -15 38 21 13 -34 175 263
2021 0.0384 -0.268 444 484 4 -77 33 25 -13 -189 191 250
2022 -0.0696 -0.684 484 501 -8 -167 43 -126 -118 -195 283 355
2023 -1.1600 -0.174 509 588 -144 -78 -83 -139 -153 -214 310 390
2024 -0.7000 0.069 591 661 -87 8 -6 11 -96 -66 313 342
2025 - 0.201 - 724 - 25 - 12 - -73 - 374
2026 - 0.370 - 793 - 1.F11X - 1.F111 - 1.F1111 - 1.F1111
2027 - 0.450 - 862 - 0.F12X - 0.F121 - 0.F1211 - 0.F1211
Institutional Sentiment
Morgan Stanley
1Y Ago:
n/a
Prev. Grade
n/a
n/a
JP Morgan Chase
1Y Ago:
n/a
Prev. Grade
n/a
n/a
Citigroup
1Y Ago:
n/a
Prev. Grade
n/a
n/a
Overall Consensus
Grading Consensus
Price Target Consensus

-36.303% $5.46 · MISS

Nov. 6, 2024
Price Then
$14.93
Price Target
$20.50
Price Now
$15.04